Valeant Publishes Rebuttals to Short-Sellers

New Post Public Reply Private Reply Replies (0) Message Board
InstitutionalTR
Valeant Publishes Rebuttals to Short-Sellers Lies

Short-sellers are losing ground with VRX. The stock was up more than 3% intraday before discredited Bronte Capital, the so called "hedge fund" run by 2 people, published a list of lies that VRX quickly rebutted.

Short-sellers profit by destroying reputation of reputable and well-established companies like Valeant Pharmaceuticals. They do this by posting misleading and inaccurate information online.

Now Valeant Pharmaceuticals is fighting back. Today, VRX published Corrections to Misleading Comments:

Read it here: http://www.valeant.com/about/corrections
PDF: http://www.valeant.com/Portals/25/PDF/1125201...buttal.pdf

Bausch Health Companies Inc. (BHC) Stock Research Links

BHC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

How Neo Pepe Coin is Capturing Investor Attention with Presale Growth

Updated Category News Views 165

Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...

Continue Reading
Upcoming Conference Call for Bio-Techne's Q1 2025 Insights

Updated Category News Views 70

Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...

Continue Reading
Modella AI's PathChat DX Receives Major FDA Recognition

Updated Category News Views 373

Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...

Continue Reading
Nicholas Wealth Unveils New Distribution Rate for FIAX ETF

Updated Category News Views 116

Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...

Continue Reading
Understanding Voting Rights and Capital in Investments

Updated Category News Views 191

Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...

Continue Reading